Therapy for Advanced NSCLC With EGFR 19delins Mutation
Clinical trial NCT07458919 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07458919
- Sponsor
- Fuzhou General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2030-10-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.